Get the app
US › Healthcare

Cyclerion Therapeutics Inc (CYCN)

US · Healthcare · Biotechnology

—

Latest quarter · ended 2026-06-30

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-1.8M
EPS
$-0.41

Key statistics

Market cap
$15.7M
Forward P/E
0.0
P/B
3.15
Book value
$8.37
EPS (TTM)
$-11.62
52-week high
$59.36
52-week low
$7.19
50-day MA
$26.37
200-day MA
$18.35
Beta
1.75

Analyst view

Analysts rate Cyclerion Therapeutics Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $56.00.

Shareholding

Insiders
21.70%
Institutions
70.86%

Largest institutional holders

FundStake
Geode Capital Management, LLC1.81%
Citadel Advisors Llc0.39%
BlackRock Inc0.36%
Vanguard Capital Management, LLC0.34%
Dimensional Fund Advisors, Inc.0.25%
Kovack Advisors Inc0.21%
Vanguard Fiduciary Trust Co0.16%
FMR Inc0.10%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cyclerion Therapeutics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.